[ad_1]
NEW YORK (Reuters Health) – A drug used to kill mosquitoes can reduce the chances of getting malaria in young children by 20%, according to a new study.
The study, published in the March issue of the journal Lancet, revealed that repeated management of ivermectin every three weeks during the malaria transition season could reduce the incidence of Malaria 20% in children 5 years old or younger.
Ivermectin is commonly used to treat parasitic infections such as river blindness and lice mange.
"Ivermectin reduces new cases of malaria by making the person's blood deadly to the mosquitoes that kill it, thus reducing the risk of injury to other people," said Bryan de Foi, a researcher at the University of California. University of Colorado.
"Since ivermectin is a unique method compared to other insecticides to fight malaria and malaria, it can be used in combination with drugs that treat malaria to fight the transmission of the remaining disease. "
In this study, the research team initiated a test to verify the safety and efficacy of the use of the drug "Ivermectin", a complete and repeated control of malaria during the experiment, which lasted 18 weeks.
The team included 2,700 people, including 590 children, from eight villages in Burkina Faso in West Africa. All qualified residents – 1,080 in the income group and 999 in the control group – received a single dose of 150 to 200 micrograms / kg of Ivermectin plus 400 mg of albendazole – an anthelmintic drug. five more doses three times more than Ivermectin alone.
Since 2000, the number of deaths from malaria has decreased by 48% worldwide and the number of infected areas is reduced, but the increased resistance to artemisinin, which is an integral part of this success, has been curbed.
[ad_2]
Source link
